Do patient characteristics affect EGFR tyrosine kinase inhibitor treatment outcomes? A network meta‐analysis of real‐world survival outcomes of East Asian patients with advanced non‐small cell lung cancer treated with first‐line EGFR‐TKIs

Abstract Background Despite the well‐established efficacies of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR)‐mutated non‐small cell lung cancer (NSCLC), there is limited real‐world evidence comparing their effectiveness according to patients’ clinical characteristics....

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Huang‐Chih Chang, Chin‐Chou Wang, Chia‐Cheng Tseng, Kuo‐Tung Huang, Yu‐Mu Chen, Yu‐Ping Chang, Chien‐Hao Lai, Wen‐Feng Fang, Meng‐Chih Lin, Hung‐Yi Chuang
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wiley 2023-11-01
Ráidu:	Thoracic Cancer
Fáttát:	first‐line EGFR‐TKI network meta‐analysis non‐small cell lung cancer overall survival
Liŋkkat:	https://doi.org/10.1111/1759-7714.15111
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!